Join a Webinar

The first quarter of 2024 started with a bang. LPS completed over $100 million of IDSO partnerships, most at new record values. Over $3.0 billion of new financing and capital was invested in multiple existing and new GP and specialty IDSOs. With the world’s largest investor, Blackrock ($10.0 TRILLION under management) doubling down with their second IDSO investment in less than 14 months, more sophisticated, global investors are eagerly pouring capital into U.S. IDSOs.

It is not just private equity investing as the little advisors and doctors seem to think. Interest rates have added more IDSOs to the LPS Blacklist (the 500+ IDSOs we will not let bid on our clients), but new capital is enabling high values for growing practices nationally.

Join us for a fast paced 57-minute webinar to learn the latest updates on U.S. dental practice values and our forecast for the balance of 2024. A lot is changing. We will be open to all questions!

Topics we will cover include:

• How many bidders it took to hit 11x EBITDA for a Pedo/Ortho practice
• The smallish GP who had a 6x offer in hand but ended up at 8.5x thanks to LPS
• The miracle OMS practice deal at 11x EBITDA with a Dental Trifecta
• The hottest states in Q1 2024 were NOT FL, TX, AZ, TN, SC, ID or UT
• How LPS helped start our sixth new IDSO with an experienced investor and a great client
• Why your low margins are valuable in an earnout
• Which IDSOs are paying 30% less than you are for supplies

Join us for a special fast paced 58-minute webinar

 Topics we will cover include:

• Why an LPS ortho client got 12x+ EBITDA in 2023
• How 3x collections is achieved regularly in ortho by LPS
• Ortho practice attributes that generate the most qualified bidders
• Which Ortho Only IDSOs may not make it in their current form
• Learn why in the last 24 months, over $150 million dollars of LPS clients were under 40.

All dental specialists have uniquely different options from GP practices in IDSO partnerships. Specialists will typically achieve higher values and have more qualified bidders from which to choose their ideal IDSO silent partner. In the last seven years, dozens of single and multispecialty IDSOs have been formed by sophisticated, experienced investors. Many have already had high value recapitalizations.

In this fast paced, 62-minute webinar we will discuss the various options available for all specialists at record values in 2024. In 2023, LPS achieved values of over 10x EBITDA for every type of specialty practice except Endodontics, where we got close! In our $1.0 billion of completed IDSO partnerships in 2022 and 2023, most specialty clients had six or more qualified bidders.

• OMS: Learn which of the 17 OMS only IDSOs will probably fail and why Dental Trifectas may be a better option.
• Ortho: Some of the 14 ortho only IDSOs are having challenges due to case start drops, others are flourishing.
• Pedo: Even those with a heavy Medicaid component have new options due to the world’s largest investor joining the IDSO frenzy.
• Perio: Implant focused practices have multiple new options and the multispecialty IDSOs are the most eager.
• Endo: The Surgical Trifecta IDSOs are still eager for many geographies and value practices higher than Endo Only IDSOs.
• Prosth: Doctor age and multiple doctors drive up value. Implant: All on X financing sources and marketing tools are critical to success today. IDSOs have mastered both.

Join us for a special fast paced 59-minute webinar

 Topics we will cover include:

• Why an IDSO may or may not be a fit for you
• What is driving doctors as young as 30 to partner with an IDSO today
• The risks and rewards of IDSO partnership
• When is the right time to consider IDSO partnership 
• What happens when a competitor or a referral source joins an IDSO?

The business of dentistry is changing rapidly. You owe it to yourself to at least understand what is coming to your area or already there now. If you have a larger practice, the old doctor buy in/buy out model is not your most valuable path. You will ultimately join an IDSO or compete with many.